Search for: "Gordon v. Dawson" Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Oct 2007, 12:43 pm
Dawson County Includes the city of Dawsonville. [read post]
5 May 2019, 4:41 pm by INFORRM
In the case of Dawson v D C Thomson & Co [2019] ScotSAC (Civ), the Sheriff Appeal Court has dismissed an appeal carer who unsuccessfully sued a local newspaper for defamation. [read post]
14 May 2021, 7:10 am by Arturo Jara
” I Am Sam Plot: Sam Dawson is a single father with an intellectual disability raising his 7-year-old daughter. [read post]
30 Nov 2007, 7:02 am
Center Great Plains Disability and Business Technical Assistance Center University of Missouri/Columbia 100 Corporate Lake Drive Columbia, MO 65203 Phone: (573) 882-3600 (V/TTY); (800) 949-4232 (V/TTY/Toll Free) E-mail: ada@missouri.edu Web: http://www.adaproject.org ASSISTIVE TECHNOLOGY Technology-Related Assistance Nebraska Assistive Technology Partnership 5143 South 48th Street, Suite C Lincoln, NE 68516-2204 Phone: (402) 471-0734 (V/TTY); (888) 806-6287… [read post]
18 Jul 2012, 5:57 am by Rob Robinson
.: Taking A Step Back - http://bit.ly/Lt2hP4 (Cynthia Courtney) Plaintiffs v. [read post]
15 Nov 2007, 7:21 am
Phone: (404) 881-0292 Fax: (404) 881-6997 E-mail: gaaarp@aarp.org Web: http://www.aarp.orgga ADA Regional ADA & IT Technical Assistance Center Southeast Disability and Business Technical Assistance Center Center for Assistive Technology and Environmental Access Georgia Tech, 490 10th Street Atlanta, GA 30318 Phone: (404) 385-0636; (800) 949-4232 (V/TTY/Toll Free) E-mail: sedbtac@catea.org Web: http://www.sedbtac.org Georgia ADA Exchange 4164 Admiral Drive Chamblee, GA 30341… [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]